Cancer Research AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ushijima, T.
Right arrow Articles by Nagao, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ushijima, T.
Right arrow Articles by Nagao, M.
[Cancer Research 60, 1092-1096, February 15, 2000]
© 2000 American Association for Cancer Research


Molecular Biology and Genetics

Chromosomal Mapping of Genes Controlling Development, Histological Grade, Depth of Invasion, and Size of Rat Stomach Carcinomas1

Toshikazu Ushijima2, Masami Yamamoto, Masumi Suzui, Takashi Kuramoto, Yukinari Yoshida, Tomoko Nomoto, Masae Tatematsu, Takashi Sugimura and Minako Nagao

Carcinogenesis Division, National Cancer Center Research Institute, Tokyo 104-0045, Japan [T. U., M. S., T. K., Y. Y., T. N., T. S., M. N.], and Department of Pathology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan [M. Y., M. T.]

Rat stomach cancers induced by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) are widely used as a model of differentiated-type human stomach cancers. ACI/N (ACI) rats are susceptible and BUF/Nac (BUF) rats are resistant to MNNG-induced stomach carcinogenesis, and the presence of an autosomal gene with a dominant BUF allele has been suggested. In this study, we performed a carcinogenicity test by giving MNNG in drinking water to 117 male ACI x (ACIxBUF)F1 backcross rats. Each of 100 effective rats was diagnosed for its "carcinoma development" and when it was bearing stomach carcinoma(s), for histological grade, depth of invasion, and size and number of tumors. Carcinoma development was diagnosed based both on the age of the rat and on the presence of stomach carcinoma(s). Linkage analysis was performed with the genotypes of 161 loci, covering 1637 cM of the rat genome. Contrary to our original expectations, the most influential gene was the one on chromosome (chr.) 15, Gastric cancer susceptibility gene 1 (Gcs1), which confers susceptibility to stomach carcinogenesis (LOD, 3.8) with a dominant BUF allele by promoting conversion from adenomas to carcinomas. Two resistance genes on chr. 4 and chr. 3, Gastric cancer resistance gene 1 (Gcr1) and Gcr2, were shown to confer dominant resistance (LOD, 2.7 and 2.6, respectively). Gcs1, Gcr1, and Gcr2 exerted additive effects on the development of stomach carcinomas. A gene on chr. 16, Gcr3, was indicated to reduce the depth of invasion (LOD, 2.2) and sizes of tumors (LOD, 1.9). No linkage was obtained using the number of tumors. These findings show that the coordinate effect of a susceptibility gene, Gcs1, and two resistance genes, Gcr1 and Gcr2, is responsible for the development of MNNG-induced stomach carcinomas and that Gcr3 is responsible for the growth of a stomach carcinoma, reflected in the depth of invasion and in the tumor size.




This article has been cited by other articles:


Home page
GeneticsHome page
J. R. Sheng, M. Jagodic, I. Dahlman, K. Becanovic, R. Nohra, M. Marta, E. Iacobaeus, T. Olsson, and E. Wallstrom
Eae19, a New Locus on Rat Chromosome 15 Regulating Experimental Autoimmune Encephalomyelitis
Genetics, May 1, 2005; 170(1): 283 - 289.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Yamashita, S. Suzuki, T. Nomoto, Y. Kondo, K. Wakazono, Y. Tsujino, T. Sugimura, T. Shirai, Y. Homma, and T. Ushijima
Linkage and Microarray Analyses of Susceptibility Genes in ACI/Seg Rats: A Model for Prostate Cancers in the Aged
Cancer Res., April 1, 2005; 65(7): 2610 - 2616.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Chakroborty, C. Sarkar, R. B. Mitra, S. Banerjee, P. S. Dasgupta, and S. Basu
Depleted Dopamine in Gastric Cancer Tissues: Dopamine Treatment Retards Growth of Gastric Cancer by Inhibiting Angiogenesis
Clin. Cancer Res., July 1, 2004; 10(13): 4349 - 4356.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
P J Hu, J Yu, Z R Zeng, W K Leung, H L Lin, B D Tang, A H C Bai, and J J Y Sung
Chemoprevention of gastric cancer by celecoxib in rats
Gut, February 1, 2004; 53(2): 195 - 200.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. A. Dragani
10 Years of Mouse Cancer Modifier Loci: Human Relevance
Cancer Res., June 15, 2003; 63(12): 3011 - 3018.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Yamashita, K. Furumoto, A. Nobukiyo, M. Kamohara, T. Ushijima, and T. Furukawa
Mapping of A Gene Responsible for Cataract Formation and Its Modifier in the UPL Rat
Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3153 - 3159.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Yamashita, K. Wakazono, T. Sugimura, and T. Ushijima
Profiling and selection of genes differentially expressed in the pylorus of rat strains with different proliferative responses and stomach cancer susceptibility
Carcinogenesis, June 1, 2002; 23(6): 923 - 928.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.